# EDGAR Filing Document

**Accession Number:** 0002075310
**File Stem:** 0000000000-25-008326
**Filing Date:** 2025-8
**Character Count:** 7265
**Document Hash:** d6331e5f4d00cbe4bedff84b450be922
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008326.hdr.sgml**: 20260113

**ACCESSION NUMBER**: 0000000000-25-008326

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250808

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Trailblazer Acquisition Corp.
- **CENTRAL INDEX KEY:** 0002075310
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-288651

**BUSINESS ADDRESS:**
- **STREET 1:** 152 WEST 57TH STREET, 27TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 212-621-8777

**MAIL ADDRESS:**
- **STREET 1:** 152 WEST 57TH STREET, 27TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-25-063342

## Text-Extract

```

                                                             August 7, 2025

Eric Semler
Chief Executive Officer
Trailblazer Acquisition Corp.
152 West 57th Street, 27th Floor
New York, NY 10019

       Re: Trailblazer Acquisition Corp.
           Registration Statement on Form S-1
           Filed July 11, 2025
           File No. 333-288651
Dear Eric Semler:

       We have reviewed your registration statement and have the following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Registration Statement on Form S-1
Cover Page

1.     We note your disclosure that you may pay finder's fees, advisory fees,
consulting fees,
       success fees or salaries to your sponsor, officers, directors or their
affiliates. On page
       36 and elsewhere, you refer to this fee only being paid to independent
directors.
       Please revise your disclosure, as appropriate, to address this
discrepancy. Please also
       describe the extent to which the conversion of the working capital loans
into warrants
       and their cashless exercise, for example, may result in a material
dilution of the
       purchasers' equity interests. See Item 1602(a)(3) of Regulation S-K.
Please make
       similar revisions to your disclosure on pages 10 and 111. See Items
1602(b)(6) and
       1603(a)(6) of Regulation S-K.
2.     When discussing conflicts of interest in paragraphs 6 and 7, please
expand your
       statement as to actual or potential material conflicts of interest
between purchasers in
       the offering and the SPAC sponsor and its affiliates, to include
promoters . Refer to
 August 7, 2025
Page 2

       Item 1602(a)(5) of Regulation S-K.
Conflicts of Interest, page 35

3.     We note your disclosure on page 35 that your "sponsor, officers, or
directors or their
       respective affiliates may sponsor or form other special purpose
acquisition companies
       similar to [yours] or may pursue other business or investment ventures
during the
       period in which [you] are seeking an initial business combination."
Please clarify how
       opportunities to acquire targets will be allocated among SPACs. Please
make similar
       revisions to your disclosure on page 143. Please refer to Items
1602(b)(7) and 1603(b)
       of Regulation S-K.
Dilution, page 94

4.     Please revise your dilution table to include the label    Assuming No
Exercise of Over-
       Allotment Option    in the appropriate location.
Proposed Business
Sponsor Information, page 110

5.     We note your disclosure on your cover page that "[your] sponsor
transferred 25,000
       founder shares to each of our independent directors and 15,000 founder
shares to our
       Chief Financial Officer (an aggregate of 90,000 founder shares) as
compensation for
       their services." Please revise to provide all of the disclosure required
by Item
       1603(a)(7) of Regulation S-K, including any direct or indirect interests
to be received
       by your independent directors. Please also revise your disclosure on
page 140 as
       appropriate. Please refer to Item 402(r)(3) of Regulation S-K.
Sourcing of Potential Business Combination Targets, page 114

6.     We note your disclosure states: "We have not contacted any of the
prospective target
       businesses that our management team in their prior SPACs had considered
and
       rejected as target businesses to acquire." Please revise the appropriate
section or
       sections of your document to describe any experience your sponsor,
officers and
       directors have had experience in organizing a SPAC. For each prior SPAC,
please
       disclose any extensions of the time to complete the transaction and the
level of
       redemptions in connection therewith, and information concerning any
completed
       business combinations, including the financing needed for the
transactions and the
       level of redemptions. See Item 1603(a)(3) of Regulation S-K. To the
extent your
       sponsor, officers and directors do not have experience in organizing
SPACs, please
       add a separate risk factor highlighting this fact.
Part II. Information not Required in Prospectus
Item 16. Exhibits and Financial Statement Schedules, page II-2

7.     We note that the hyperlink to exhibit 10.1 currently leads to the
Investment
       Management Trust Agreement, and the hyperlink to exhibit 10.2 currently
leads to the
       Letter Agreement. Please update to provide the correct hyperlinks.
Please refer to Item
       601(a)(2) of Regulation S-K.
8.     We note your disclosure on page 185 and elsewhere that the underwriter
       may purchase an aggregate of up to 3,000,000 additional units in the
over-allotment
 August 7, 2025
Page 3

       option. Please have counsel revise clause (a) of the opinion to reflect
this.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Jeffrey Lewis at 202-551-6216 or Jennifer Monick at
202-551-3295 if
you have questions regarding comments on the financial statements and related
matters. Please contact Stacie Gorman at 202-551-3585 or David Link at
202-551-3356 with
any other questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of Real
Estate & Construction
cc:   Stuart Neuhauser, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._